How Much Did Euphrates Vascular Raise?
Funding & Key Investors

Euphrates Vascular has successfully secured a significant capital injection, marking a pivotal moment in its corporate trajectory. With a total cumulative investment reaching $137K, the firm continues to solidify its market presence. This latest infusion of $137K serves as a major strategic investment, providing the necessary liquidity to accelerate the commercialization of its proprietary nanotechnology-driven medical solutions.

What is Euphrates Vascular?

Euphrates Vascular
ManufacturingMedical Devices & Equipment

Euphrates Vascular operates at the intersection of advanced nanotechnology and interventional cardiology. The company is primarily recognized for its Pulse NanoMED system, a sophisticated platform engineered to address distal vessel occlusions that remain inaccessible via conventional surgical tools. By targeting high-acuity conditions such as Acute Ischemic Stroke, Peripheral Artery Disease, and ST Elevated Myocardial Infarction, the firm addresses critical gaps in current vascular intervention standards. Their market position is defined by a commitment to optimizing blood flow restoration, which not only improves clinical patient outcomes but also addresses the broader health economics of vascular care. Through the integration of nanotechnology, Euphrates Vascular is effectively redefining the precision of minimally invasive procedures.

How much funding has Euphrates Vascular raised?

Euphrates Vascular has raised a total of $137K across 1 funding round:

2021

Debt

$137K

Debt (2021): $137K with participation from PPP

Key Investors in Euphrates Vascular

PPP

Public-Private Partnership

What's next for Euphrates Vascular?

With this late-stage financing secured, Euphrates Vascular is positioned to scale its operational footprint and expand the clinical adoption of the Pulse NanoMED system. The strategic roadmap likely involves intensifying regulatory engagement to broaden the indications for their flagship technology and scaling manufacturing capabilities to meet anticipated demand in global markets. As the company transitions from a development-focused entity to a commercial-stage leader, the focus will shift toward long-term clinical validation and the establishment of robust distribution networks. Investors are closely monitoring the firm's ability to translate its technological edge into sustained market share within the competitive vascular intervention landscape, particularly as it seeks to disrupt traditional treatment paradigms for complex occlusions.

See full Euphrates Vascular company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Cosmetics, Beauty Supply & Personal Care ProductsManufacturingRetailFlowers, Gifts & Specialty Stores
Building MaterialsManufacturingHome Improvement & Hardware RetailRetail
Industrial Machinery & EquipmentManufacturingAutomobile Parts StoresAutomotive PartsRetail
ElectronicsManufacturing

Frequently Asked Questions Regarding Euphrates Vascular Financial Insights

What are the most recent funding rounds that Euphrates Vascular has completed, and what were the funding rounds?
Euphrates Vascular has recently completed 1 funding rounds: Debt on Feb 4, 2021.
What is the total amount of funding Euphrates Vascular has raised to date?
Euphrates Vascular has raised a total of $137K in funding to date.
How many funding rounds has Euphrates Vascular completed?
Euphrates Vascular has completed 1 funding rounds.
How much funding did Euphrates Vascular raise in its most recent funding round?
Euphrates Vascular raised $137K in its most recent funding round.
Who are the lead investors in Euphrates Vascular's latest funding round?
The lead investor in Euphrates Vascular's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Euphrates Vascular's history?
The largest funding round in Euphrates Vascular's history was $137K.
See more information about Euphrates Vascular